Nanoligent
ID: 7645534Nanoligent is a developer of precision nanodrugs for cancer treatment founded in 2017 by Ramon Mangues.
3
Funding Rounds
$16.9m
Money raised
Recent Funding Rounds
Overview
Nanoligent is a developer of precision nanodrugs for cancer treatment founded in 2017 by Ramon Mangues.
- Website:
- Business model: B2B
- Headquarters: Barcelona
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ra*** Ma***** |
|
- | |
| Ma**** Ro******* | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Nanoligent has raised a total of $16.9m in funding over 3 rounds.
Key Insights:
- Nanoligent Series A Round, October 2025: $14m
- Nanoligent September 2022 Seed Funding Round: $1.8m
- Nanoligent January 2022 Seed Funding Round: $1.1m
Industries
Nanoligent is active in the following industries: